Adipogenic differentiation alters the immunoregulatory property of mesenchymal stem cells through BAFF secretion

References

• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al.. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al.. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11–20.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger M. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815–22.
   PubMed Web of Science ®Google Scholar
• Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, et al.. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness. Blood 2005;105:2214–9.
   PubMed Web of Science ®Google Scholar
• Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al.. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107:367–72.
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484–90.
   PubMed Web of Science ®Google Scholar
• Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006;24:74–85.
   PubMed Web of Science ®Google Scholar
• Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al.. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005;105:4120–6.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G, Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007;83:71–6.
   PubMed Web of Science ®Google Scholar
• Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al..: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101, 3722–3729.
   PubMed Web of Science ®Google Scholar
• Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P.: Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003, 171, 3426–3434.
   PubMed Web of Science ®Google Scholar
• Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC.: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75, 389–397.
   PubMed Web of Science ®Google Scholar
• Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al.. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837–44.
   PubMed Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase- mediated tryptophan degradation. Blood 2004;103:4619–21.
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al.. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42–8.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, et al.. Cotransplantation of HLA-identical sibling culture- expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389–98.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al.. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al.. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005;106:1755–61.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al.. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932–7.
   PubMed Web of Science ®Google Scholar
• Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002;30:215–22.
   PubMed Web of Science ®Google Scholar
• Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al.. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307–16.
   PubMed Web of Science ®Google Scholar
• Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AB, Deans R, et al.. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282–6.
   PubMed Web of Science ®Google Scholar
• MacDonald DJ, Luo J, Saito T, Duong M, Bernier PL, Chiu RC, et al.. Persistence of marrow stromal cells implanted into acutely infarcted myocardium: Observations in a xenotransplant model. J Thorac Cardiovasc Surg 2005;130:1114–21.
   PubMed Web of Science ®Google Scholar
• Grinnemo KH, Mansson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al.. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 2004;127:1293–300.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 2005;115:911–9.
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi BH, Do MS. The interaction of adipose tissue with immune system and related inflammatory molecules. Immune Network 2006;6:169–78.
   Google Scholar
• Tilg H, Moschen AR. Adipokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–83.
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi BH, Cheon HG, Do MS. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009;41:208–16.
   PubMed Web of Science ®Google Scholar
• Do MS, Jeong HS, Choi BH, Hunter L, Langley S, Pazmany L, et al.. Inflammatory gene expression patterns revealed by DNA microarray anaysis in TNF-α-treated SGBS human adipocytes. Yonsei Med J 2006;47:729–36.
   PubMed Web of Science ®Google Scholar
• Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 2006;312:2169–79.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006;36:2566–73.
   PubMed Web of Science ®Google Scholar
• Chen X, McClurg A, Zhou GQ, McCaigue M, Armstrong MA, Li G. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells 2007;25:364–70.
   PubMed Web of Science ®Google Scholar
• Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875–84.
   PubMed Web of Science ®Google Scholar
• Tse WT, Beyer W, Pendleton JD, D’Andrea A, Guinan EC. Bone marrow derived mesenchymal stem cells suppress T cell activation without inducing allogeneic anergy. Blood 2000;96:1034a.
   Web of Science ®Google Scholar
• Huard B, Schneider P, Mauri D, Tschopp J, French LE. T cell co-stimulation by the TNF ligand BAFF. J Immunol 2001;167:6225–31.
   PubMed Web of Science ®Google Scholar
• Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, et al.. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004;173:807–17.
   PubMed Web of Science ®Google Scholar
• Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al.. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999;189:1747–56.
   PubMed Web of Science ®Google Scholar
• Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 2010;6:195–213.
   PubMed Web of Science ®Google Scholar
• Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, et al.. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004;33:597–604.
   PubMed Web of Science ®Google Scholar